The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | Targeted therapy in MM
Sagar Lonial, MD, Emory University School of Medicine, Atlanta, GA, Enrique Ocio, Marquis de Valdecilla University Hospital, Santander, Spain, and Rafael Fonseca, MD, Mayo Clinic, Scottsdale, AZ, speaking at a roundtable meeting at the International Myeloma Workshop (IMW) 2019, held in Boston, MA. The speakers discuss targetted therapy including MCL1 and BCL2 and related clinical trials.
